Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Resource Utilization
100%
Hospitalization
100%
Resource Cost
100%
Carvedilol
100%
Heart Failure Incidence
100%
Heart Failure
40%
Disease Severity
20%
Placebo
20%
Hospitalization Risk
20%
Inpatient Care
20%
Hospital Admission
20%
Cardiovascular Admissions
20%
Length of Stay
20%
Hospitalized Patients
10%
Disease Progression
10%
Health Care Costs
10%
Infection Risk
10%
Heart Failure Hospitalization
10%
Intensive Care
10%
Intensive Care Unit
10%
Resource Use
10%
Frequent Use
10%
Placebo-controlled Study
10%
Number of Hospitalization
10%
Cardiovascular Hospitalizations
10%
New York Heart Association Class
10%
Coronary Care Unit
10%
Patients with Chronic Heart Failure
10%
Angiotensin-converting Enzyme Inhibition
10%
Heart Failure Trials
10%
Utilization Data
10%
Heart Failure Admission
10%
Nursing and Health Professions
Congestive Heart Failure
100%
Carvedilol
100%
Placebo
20%
Length of Stay
20%
Diseases
20%
Disease Exacerbation
10%
Intensive Care
10%
Intensive Care Unit
10%
Randomization
10%
New York Heart Association Class
10%
Coronary Care Unit
10%
Placebo-Controlled Study
10%
Dipeptidyl Carboxypeptidase
10%